Now's the time to invest in biotech, according to VCs who've analyzed 1,227 early-stage biotech startups. Here's why they're so sure.
This is a Business Insider Prime story. Click the link below to read it.
- In highest single-day spike, nearly 23k test positive for COVID; death toll rises to 18,655
- PubG witnesses highest downloads in India with 175 million installs — taking its global revenues to $1.3 billion
- EU regulators begin closer scrutiny of $2.1bn Google-Fitbit deal
- All districts except one in Kashmir categorised as red zones
- Apple survey prods iPhone users about power adapters' use